Directory
>
Rick Blidner
Rick Blidner
Vice President Molecular Assay Development | Tempus AI
Chicago, Illinois, United States
Rick Blidner
Summary
Rick Blidner is a seasoned Vice President of Molecular Assay Development at Tempus, Inc., with over a decade of experience in the biotechnology and diagnostics sectors. He possesses a strong technical background in assay development, molecular biology, and product development, complemented by his leadership skills that enable him to drive projects to successful completion. Rick has a proven ability to innovate and implement process improvements that enhance operational efficiency. His expertise extends to various cutting-edge technologies, including biosensors and nanotechnology. Throughout his career, he has demonstrated a commitment to mentoring teams and fostering a collaborative work environment. Rick's educational foundation in biomedical engineering and bioengineering further supports his technical acumen. He is particularly interested in emerging technologies and sustainability within the life sciences industry.
Rick Blidner
Work Experience
Vice President Molecular Assay Development at
Tempus AI
February 2022 - Present
Senior Director Molecular Assay Development at
Tempus
June 2019 - February 2022
R&D Site Leader, Senior Manager Diagnostics at
PerkinElmer
March 2018 - June 2019
Group Leader at
Asuragen, a Bio-Techne brand
March 2015 - March 2018
Principal Scientist - Product Development at
Nanōmix
November 2010 - February 2015
Scientist & Engineer at
Investigen
July 2008 - November 2010
Laboratory Manager / Research Associate at
Louisiana State Univeristy
August 2003 - December 2007
Surgical Tissue Recovery Technician at
Southern Eye Bank
August 2003 - November 2007
Surgical Tissue Recovery Technician at
Central Ohio Lyons Eye Bank
August 2002 - August 2003
Process Engineering Co-Op at
Ohio Polychemical Polymers
May 1999 - August 1999
Rick Blidner
Education
Louisiana State University, Phd
January 2003 - January 2007
The Ohio State University, M.S.
January 2001 - January 2003
January 1997 - January 2001
Frequently Asked Questions about Rick Blidner
What is Rick Blidner email address?
Rick Blidner's primary email address is ************@tempus.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Rick Blidner work for?
Rick Blidner is a Vice President Molecular Assay Development at Tempus AI, a company specializing in Prepackaged software.
Where Rick Blidner graduated from?
Rick Blidner holds a degree in Bioengineering, Biochemistry from Louisiana State University.
How can I directly contact Rick Blidner?
To contact Rick Blidner directly, you can use the email address ************@tempus.com. Complete contact information is available upon registration with Muraena.
Who is Rick Blidner?
Rick Blidner is a seasoned Vice President of Molecular Assay Development at Tempus, Inc., with over a decade of experience in the biotechnology and diagnostics sectors. He possesses a strong technical background in assay development, molecular biology, and product development, complemented by his leadership skills that enable him to drive projects to successful completion. Rick has a proven ability to innovate and implement process improvements that enhance operational efficiency. His expertise extends to various cutting-edge technologies, including biosensors and nanotechnology. Throughout his career, he has demonstrated a commitment to mentoring teams and fostering a collaborative work environment. Rick's educational foundation in biomedical engineering and bioengineering further supports his technical acumen. He is particularly interested in emerging technologies and sustainability within the life sciences industry.
Rick`s contact details
************@tempus.com
Colleagues
VP, Translational Science
VP Oncology Sales, North America
Area Vice President, Life Sciences
VP of Life Science Revenue Operations
Vice President Clinical Pathology
Chief Accounting Officer (CAO)
Advisor
Vice President of Commercial Markets
Divisional Vice President, Head of Pharma Sequencing and CDx
Chief Privacy Officer